Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

D G Evans, L Trueman, A Wallace, S Collins, T Strachan

Department of Medical Genetics, St Mary's Hospital, Manchester, UK.

Blood samples from 125 unrelated families with classical type 2 neurofibromatosis (NF2) with bilateral vestibular schwannomas have been analysed for mutations in the NF2 gene. A further 17 families fulfilling modified criteria for NF2 have also been analysed. Causative mutations have been identified in 54 (43%) classical families and six (35%) of those fulfilling modified criteria. Forty-two cases from 38 families with truncating mutations had an average age at onset of symptoms of 19 years and diagnosis at 22.4 years. Fifty-one cases from 16 families with splice site mutations (15 from six), missense mutations (18 from six), and large deletions (18 from five) had an average age of onset of 27.8 years and at diagnosis of 33.4 years. Subjects with truncating mutations were significantly more likely to have symptoms before 20 years of age (p<0.001) and to develop at least two symptomatic CNS tumours in addition to vestibular schwannoma before 30 years (p<0.001). There were also significantly fewer multigenerational families with truncating mutations. Four further truncating mutations were in mosaic form and were associated with milder disease than other similar mutations. This large study has confirmed the previous impression that truncating mutations are associated with severe disease, but caution has to be exercised in using mutation type to predict disease course.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Evans, D G. R, Ramsden, R T, Shenton, A, Gokhale, C, Bowers, N L, Huson, S M, Pichert, G, Wallace, A (2007). Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J. Med. Genet. 44: 424-428 [Abstract] [Full Text]  
• Ryan, A. M., Hurley, M., Brennan, P., Moroney, J. T. (2005). Vascular dysplasia in neurofibromatosis type 2. Neurology 65: 163-164 [Full Text]  
• Baser, M E, Kuramoto, L, Woods, R, Joe, H, Friedman, J M, Wallace, A J, Ramsden, R T, Olschwang, S, Bijlsma, E, Kalamarides, M, Papi, L, Kato, R, Carroll, J, Lazaro, C, Joncourt, F, Parry, D M, Rouleau, G A, Evans, D G R (2005). The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J. Med. Genet. 42: 540-546 [Abstract] [Full Text]  
• Diebold, R., Bartelt-Kirbach, B., Evans, D. G., Kaufmann, D., Hanemann, C. O. (2005). Sensitive Detection of Deletions of One or More Exons in the Neurofibromatosis Type 2 (NF2) Gene by Multiplexed Gene Dosage Polymerase Chain Reaction. J. Mol. Diagn. 7: 97-104 [Abstract] [Full Text]  
• Tsilchorozidou, T, Menko, F H, Lalloo, F, Kidd, A, De Silva, R, Thomas, H, Smith, P, Malcolmson, A, Dore, J, Madan, K, Brown, A, Yovos, J G, Tsaligopoulos, M, Vogiatzis, N, Baser, M., Wallace, A J, Evans, D G R (2004). Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2. J. Med. Genet. 41: 529-534 [Full Text]  
• Warren, C, James, L A, Ramsden, R T, Wallace, A, Baser, M E, Varley, J M, Evans, D G (2003). Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J. Med. Genet. 40: 802-806 [Abstract] [Full Text]  
• Baser, M E, Kuramoto, L, Joe, H, Friedman, J M, Wallace, A J, Ramsden, R T, Evans, D G R (2003). Genotype-phenotype correlations for cataracts in neurofibromatosis 2. J. Med. Genet. 40: 758-760 [Full Text]  
• Moyhuddin, A, Baser, M E, Watson, C, Purcell, S, Ramsden, R T, Heiberg, A, Wallace, A J, Evans, D G R (2003). Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J. Med. Genet. 40: 459-463 [Full Text]  
• Kluwe, L, Mautner, V, Heinrich, B, Dezube, R, Jacoby, L B, Friedrich, R E, MacCollin, M (2003). Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J. Med. Genet. 40: 109-114 [Abstract] [Full Text]  
• Kressel, M., Schmucker, B. (2002). Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15. Hum Mol Genet 11: 2269-2278 [Abstract] [Full Text]  
• Sperfeld, A. D., Hein, C., Schroder, J. M., Ludolph, A. C., Hanemann, C. O. (2002). Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125: 996-1004 [Abstract] [Full Text]  
• Bashour, A.-M., Meng, J.-J., Ip, W., MacCollin, M., Ratner, N. (2002). The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma Cells. Mol. Cell. Biol. 22: 1150-1157 [Abstract] [Full Text]  
• Baser, M. E, Friedman, J M, Evans, D G. R (2001). Maternal gene effect in neurofibromatosis 2: fact or artefact?. J. Med. Genet. 38: 783-784 [Full Text]  
• Lasota, J., Fetsch, J. F., Wozniak, A., Wasag, B., Sciot, R., Miettinen, M. (2001). The Neurofibromatosis Type 2 Gene Is Mutated in Perineurial Cell Tumors : A Molecular Genetic Study of Eight Cases. Am. J. Pathol. 158: 1223-1229 [Abstract] [Full Text]  
• Bruder, C. E.G., Hirvela, C., Tapia-Paez, I., Fransson, I., Segraves, R., Hamilton, G., Zhang, X. X., Evans, D. G., Wallace, A. J., Baser, M. E., Zucman-Rossi, J., Hergersberg, M., Boltshauser, E., Papi, L., Rouleau, G. A., Poptodorov, G., Jordanova, A., Rask-Andersen, H., Kluwe, L., Mautner, V., Sainio, M., Hung, G., Mathiesen, T., Moller, C., Pulst, S. M., Harder, H., Heiberg, A., Honda, M., Niimura, M., Sahlen, S., Blennow, E., Albertson, D. G., Pinkel, D., Dumanski, J. P. (2001). High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 10: 271-282 [Abstract] [Full Text]  
• Patronas, N. J., Courcoutsakis, N., Bromley, C. M., Katzman, G. L., MacCollin, M., Parry, D. M. (2001). Intramedullary and Spinal Canal Tumors in Patients with Neurofibromatosis 2: MR Imaging Findings and Correlation with Genotype. Radiology 218: 434-442 [Abstract] [Full Text]  
• Evans, D G. R, Sainio, M, Baser, M. E (2000). Neurofibromatosis type 2. J. Med. Genet. 37: 897-904 [Abstract] [Full Text]  
• EVANS, D G R, NEWTON, V, NEARY, W, BASER, M E, WALLACE, A, MACLEOD, R, JENKINS, J P R, GILLESPIE, J, RAMSDEN, R T (2000). Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2). J. Med. Genet. 37: 944-947 [Full Text]  
• BASER, M E, WALLACE, A J, STRACHAN, T, EVANS, D G R (2000). Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2. J. Med. Genet. 37: 542-543 [Full Text]  
• Sainio, M., Jaaskelainen, J., Pihlaja, H., Carpen, O. (2000). Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus. Neurology 54: 1132-1138 [Abstract] [Full Text]  
• Goebel, S. U., Heppner, C., Burns, A. L., Marx, S. J., Spiegel, A. M., Zhuang, Z., Lubensky, I. A., Gibril, F., Jensen, R. T., Serrano, J. (2000). Genotype/Phenotype Correlation of Multiple Endocrine Neoplasia Type 1 Gene Mutations in Sporadic Gastrinomas. J. Clin. Endocrinol. Metab. 85: 116-123 [Abstract] [Full Text]  
• Evans, D G R, Birch, J M, Ramsden, R T (1999). Paediatric presentation of type 2 neurofibromatosis. Arch. Dis. Child. 81: 496-499 [Abstract] [Full Text]  
• Giovannini, M., Robanus-Maandag, E., Niwa-Kawakita, M., van der Valk, M., Woodruff, J. M., Goutebroze, L., Mérel, P., Berns, A., Thomas, G. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev. 13: 978-986 [Abstract] [Full Text]